Literature DB >> 26378849

Overdose Epidemic, Prescription Monitoring Programs, and Public Health: A Review of State Laws.

Corey S Davis1, Jill E Johnston1, Matthew W Pierce1.   

Abstract

Prescription monitoring programs (PMPs), state-level databases that collect patient-specific prescription information at the time medications are dispensed, have been suggested as tools to address the overdose epidemic. We reviewed all laws in the United States (n = 25) that articulated the purposes PMPs are intended to serve. Attributes related to reducing abuse, misuse, and diversion of prescription medications appeared most commonly. Only 5 purpose statements mentioned the promotion of public health as goals of the PMP, and only 3 listed improving health care. None listed overdose prevention as a goal of the PMP.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26378849      PMCID： PMC4605194          DOI： 10.2105/AJPH.2015.302856

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


  12 in total

1.  Drug-poisoning deaths involving heroin: United States, 2000-2013.

Authors:  Holly Hedegaard; Li-Hui Chen; Margaret Warner
Journal:  NCHS Data Brief       Date:  2015-03

Review 2.  What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose.

Authors:  Tamara M Haegerich; Leonard J Paulozzi; Brian J Manns; Christopher M Jones
Journal:  Drug Alcohol Depend       Date:  2014-10-14       Impact factor: 4.492

3.  Discrepancies in addressing overdose prevention through prescription monitoring programs.

Authors:  Traci C Green; Sarah Bowman; Corey Davis; Cristina Los; Kimberly McHugh; Peter D Friedmann
Journal:  Drug Alcohol Depend       Date:  2015-05-18       Impact factor: 4.492

4.  Drug poisoning deaths in the United States, 1980-2008.

Authors:  Margaret Warner; Li Hui Chen; Diane M Makuc; Robert N Anderson; Arialdi M Miniño
Journal:  NCHS Data Brief       Date:  2011-12

5.  Evolution and convergence of state laws governing controlled substance prescription monitoring programs, 1998-2011.

Authors:  Corey S Davis; Matthew Pierce; Nabarun Dasgupta
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

6.  Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010.

Authors:  Christopher M Jones
Journal:  Drug Alcohol Depend       Date:  2013-02-12       Impact factor: 4.492

7.  Observed transition from opioid analgesic deaths toward heroin.

Authors:  Nabarun Dasgupta; Kathleen Creppage; Anna Austin; Christopher Ringwalt; Catherine Sanford; Scott K Proescholdbell
Journal:  Drug Alcohol Depend       Date:  2014-10-18       Impact factor: 4.492

8.  Changing law from barrier to facilitator of opioid overdose prevention.

Authors:  Corey Davis; Damika Webb; Scott Burris
Journal:  J Law Med Ethics       Date:  2013-03       Impact factor: 1.718

9.  Drug-poisoning Deaths Involving Opioid Analgesics: United States, 1999-2011.

Authors:  Li Hui Chen; Holly Hedegaard; Margaret Warner
Journal:  NCHS Data Brief       Date:  2014-09

10.  Problematic use of prescription-type opioids prior to heroin use among young heroin injectors.

Authors:  Robin A Pollini; Caleb J Banta-Green; Jazmine Cuevas-Mota; Mitcheal Metzner; Eyasu Teshale; Richard S Garfein
Journal:  Subst Abuse Rehabil       Date:  2011-10
View more
  6 in total

Review 1.  Provider perceptions of system-level opioid prescribing and addiction treatment policies.

Authors:  Rebecca L Haffajee; Cecelia A French
Journal:  Curr Opin Psychol       Date:  2019-02-04

2.  Comparing Changes in Controlled Substance Prescribing Trends by Provider Type.

Authors:  Amy L Meadows; Justin C Strickland; Shiraz Qalbani; Kailyn L Conner; Amanda Su; Craig R Rush
Journal:  Am J Addict       Date:  2019-10-10

3.  Gestational changes in buprenorphine exposure: A physiologically-based pharmacokinetic analysis.

Authors:  Hongfei Zhang; Hari V Kalluri; Jaime R Bastian; Huijun Chen; Ali Alshabi; Steve N Caritis; Raman Venkataramanan
Journal:  Br J Clin Pharmacol       Date:  2018-06-21       Impact factor: 4.335

4.  "Nobody Knows How You're Supposed to Interpret it:" End-user Perspectives on Prescription Drug Monitoring Program in Massachusetts.

Authors:  Mina Hong; Sarah Seymour; Thomas J Stopka; Lane Bandanza; Erin Crocker; Allison Morgan; Leo Beletsky
Journal:  J Addict Med       Date:  2022 May-Jun 01       Impact factor: 4.647

5.  Preventing Overdose Using Information and Data from the Environment (PROVIDENT): protocol for a randomized, population-based, community intervention trial.

Authors:  Brandon D L Marshall; Nicole Alexander-Scott; Jesse L Yedinak; Benjamin D Hallowell; William C Goedel; Bennett Allen; Robert C Schell; Yu Li; Maxwell S Krieger; Claire Pratty; Jennifer Ahern; Daniel B Neill; Magdalena Cerdá
Journal:  Addiction       Date:  2021-11-29       Impact factor: 6.526

Review 6.  Targeting practitioners: A review of guidelines, training, and policy in pain management.

Authors:  Kelly S Barth; Constance Guille; Jenna McCauley; Kathleen T Brady
Journal:  Drug Alcohol Depend       Date:  2017-04-01       Impact factor: 4.492
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.